These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27434074)

  • 1. Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study.
    Boca SM; Nishida M; Harris M; Rao S; Cheema AK; Gill K; Wang D; An L; Gauba R; Seol H; Morgenroth LP; Henricson E; McDonald C; Mah JK; Clemens PR; Hoffman EP; Hathout Y; Madhavan S
    PLoS One; 2016; 11(7):e0159895. PubMed ID: 27434074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.
    Brogna C; Coratt G; Pane M; Ricotti V; Messina S; D'Amico A; Bruno C; Vita G; Berardinelli A; Mazzone E; Magri F; Ricci F; Mongini T; Battini R; Bello L; Pegoraro E; Baranello G; Previtali SC; Politano L; Comi GP; Sansone VA; Donati A; Bertini E; Muntoni F; Goemans N; Mercuri E;
    PLoS One; 2019; 14(7):e0220714. PubMed ID: 31365579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Chu C; Balog-Alvarez C; Yu X; Cai JJ; Nabity M; Kornegay JN
    PLoS One; 2020; 15(7):e0236916. PubMed ID: 32702009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy.
    Mata López S; Balog-Alvarez C; Vitha S; Bettis AK; Canessa EH; Kornegay JN; Nghiem PP
    PLoS One; 2020; 15(10):e0241430. PubMed ID: 33091069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy.
    Hathout Y; Brody E; Clemens PR; Cripe L; DeLisle RK; Furlong P; Gordish-Dressman H; Hache L; Henricson E; Hoffman EP; Kobayashi YM; Lorts A; Mah JK; McDonald C; Mehler B; Nelson S; Nikrad M; Singer B; Steele F; Sterling D; Sweeney HL; Williams S; Gold L
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7153-8. PubMed ID: 26039989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan.
    Liang WC; Tian X; Yuo CY; Chen WZ; Kan TM; Su YN; Nishino I; Wong LC; Jong YJ
    PLoS One; 2017; 12(8):e0183406. PubMed ID: 28797072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priorities in the discovery of the implications of water channels in epilepsy and duchenne muscular dystrophy.
    Benga I
    Cell Mol Biol (Noisy-le-grand); 2006 Oct; 52(7):46-50. PubMed ID: 17543221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: a randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy.
    PLOS Currents
    PLoS Curr; 2015 Mar; 7():. PubMed ID: 25821645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and natural history of Duchenne muscular dystrophy].
    Desguerre I; Laugel V
    Arch Pediatr; 2015 Dec; 22(12 Suppl 1):12S24-30. PubMed ID: 26773582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Duchenne muscular dystrophy with autism spectrum disorder.
    Wu JY; Kuban KC; Allred E; Shapiro F; Darras BT
    J Child Neurol; 2005 Oct; 20(10):790-5. PubMed ID: 16417872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.
    Hafner P; Bonati U; Erne B; Schmid M; Rubino D; Pohlman U; Peters T; Rutz E; Frank S; Neuhaus C; Deuster S; Gloor M; Bieri O; Fischmann A; Sinnreich M; Gueven N; Fischer D
    PLoS One; 2016; 11(1):e0147634. PubMed ID: 26799743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urological manifestations of Duchenne muscular dystrophy.
    Askeland EJ; Arlen AM; Erickson BA; Mathews KD; Cooper CS
    J Urol; 2013 Oct; 190(4 Suppl):1523-8. PubMed ID: 23357214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Metabolic and taxonomic insights into the Gram-negative natural rubber degrading bacterium Steroidobacter cummioxidans sp. nov., strain 35Y.
    Sharma V; Siedenburg G; Birke J; Mobeen F; Jendrossek D; Prakash T
    PLoS One; 2018; 13(7):e0200399. PubMed ID: 29985947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III.
    Kölbel H; Hauffa BP; Wudy SA; Bouikidis A; Della Marina A; Schara U
    PLoS One; 2017; 12(4):e0175611. PubMed ID: 28384258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
    Alinezhad S; Väänänen RM; Mattsson J; Li Y; Tallgrén T; Tong Ochoa N; Bjartell A; Åkerfelt M; Taimen P; Boström PJ; Pettersson K; Nees M
    PLoS One; 2016; 11(6):e0158255. PubMed ID: 27327298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.
    Hamilton MJ; Robb Y; Cumming S; Gregory H; Duncan A; Rahman M; McKeown A; McWilliam C; Dean J; Wilcox A; Farrugia ME; Cooper A; McGhie J; Adam B; Petty R; ; Longman C; Findlay I; Japp A; Monckton DG; Denvir MA
    PLoS One; 2017; 12(4):e0175615. PubMed ID: 28384345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.
    Galindo CL; Soslow JH; Brinkmeyer-Langford CL; Gupte M; Smith HM; Sengsayadeth S; Sawyer DB; Benson DW; Kornegay JN; Markham LW
    Pediatr Res; 2016 Apr; 79(4):629-36. PubMed ID: 26672735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.
    The
    PLoS One; 2015; 10(2):e0117876. PubMed ID: 25658838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.